MAM
RXDX

Martingale Asset Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Martingale Asset Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,849
Closed -$306K – 897
2023
Q1 		$306K Buy
+2,849
New +$306K 0.01% 710